Cargando…

TIMM8A is associated with dysfunction of immune cell in BRCA and UCEC for predicting anti-PD-L1 therapy efficacy

BACKGROUND: TIMM8A is a protein-coding gene located on the X chromosome. There is evidence that TIMM8A plays an important role in mitochondrial morphology and fission. Studies have shown that mitophagy and fission could affect the function of immune cells. However, there is currently no research on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Xiaoyu, Yuan, Zile, Cheng, Sheng, Wang, Hongyi, Liao, Yuxuan, Zhou, Dawei, Wu, Zhiqiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541013/ https://www.ncbi.nlm.nih.gov/pubmed/36207751 http://dx.doi.org/10.1186/s12957-022-02736-6

Ejemplares similares

Upregulation of TIMM8A is correlated with prognosis and immune regulation in BC
por: Zhang, Yu, et al.
Publicado: (2022)

Pyroptosis-related lncRNAs are potential biomarkers for predicting prognoses and immune responses in patients with UCEC
por: Liu, Jinhui, et al.
Publicado: (2022)

Invasive fungal infections in high-risk patients: report from TIMM-8 2017
por: Pagano, Livio, et al.
Publicado: (2018)

FAM family gene prediction model reveals heterogeneity, stemness and immune microenvironment of UCEC
por: Chi, Hao, et al.
Publicado: (2023)

The mitochondrial protein TIMM44 is required for angiogenesis in vitro and in vivo
por: Ma, Zhou-rui, et al.
Publicado: (2023)

Prognostic value of TIMM50 expression in colorectal cancer
por: Sun, Bo, et al.
Publicado: (2020)

TIMM44 is a potential therapeutic target of human glioma
por: Guo, Yi-zhuo, et al.
Publicado: (2022)

A TIMM17A Regulatory Network Contributing to Breast Cancer
por: Cai, Jiajia, et al.
Publicado: (2021)

A 13-Gene Signature Based on Estrogen Response Pathway for Predicting Survival and Immune Responses of Patients With UCEC
por: Li, Yimin, et al.
Publicado: (2022)

CCNE1 is a predictive and immunotherapeutic indicator in various cancers including UCEC: a pan-cancer analysis
por: Zheng, Xingyu, et al.
Publicado: (2023)

Functional analysis of a novel mutation in the TIMM8A gene that causes deafness‐dystonia‐optic neuronopathy syndrome
por: Neighbors, Addison, et al.
Publicado: (2020)

ncRNAs-mediated high expression of TIMM8A correlates with poor prognosis and act as an oncogene in breast cancer
por: Wang, Zhonglin, et al.
Publicado: (2022)

Novel DNA Damage-Related Subtypes Characterization Identifies Uterine Corpus Endometrial Carcinoma (UCEC) Based on Machine Learning
por: Yu, Qi, et al.
Publicado: (2022)

HOXC13-driven TIMM13 overexpression promotes osteosarcoma cell growth
por: Han, Qicai, et al.
Publicado: (2023)

Identification of the prognostic value of a 2-gene signature of the WNT gene family in UCEC using bioinformatics and real-world data
por: Hu, Yuexin, et al.
Publicado: (2021)

Mutations in TIMM50 compromise cell survival in OxPhos‐dependent metabolic conditions
por: Reyes, Aurelio, et al.
Publicado: (2018)

Testing the Olze and Timme Methods for Dental Age Estimation in Radiographs of Brazilian Subadults and Adults
por: Dezem, Thaís Uenoyama, et al.
Publicado: (2021)

Neurodegenerative changes detected by neuroimaging in a patient with contiguous X-chromosome deletion syndrome encompassing BTK and TIMM8A genes
por: Szaflarska, Anna, et al.
Publicado: (2018)

TIMM13 as a prognostic biomarker and associated with immune infiltration in skin cutaneous melanoma (SKCM)
por: Zhou, Sitong, et al.
Publicado: (2022)

Visit of Stephen Timms MP, Prime Minister’s Trade Envoy for Switzerland and Liechtenstein, UK and Northern Ireland
por: Brice, Maximilien
Publicado: (2021)

Utilization of Hybrid Assembly Approach to Determine the Genome of an Opportunistic Pathogenic Fungus, Candida albicans TIMM 1768
por: Panthee, Suresh, et al.
Publicado: (2018)

Educational Session at the “Trends in Medical Mycology” (TIMM) 2021 Congress Teaching Medical Mycology to Students of Medicine
por: Segal, Esther
Publicado: (2021)

Identification of Timm13 protein translocase of the mitochondrial inner membrane as a potential mediator of liver fibrosis based on bioinformatics and experimental verification
por: Liao, Xiaomin, et al.
Publicado: (2023)

A Timm-Nissl multiplane microscopic atlas of rat brain zincergic terminal fields and metal-containing glia
por: Blixhavn, Camilla H., et al.
Publicado: (2023)

Reduced mitochondrial size in hippocampus and psychiatric behavioral changes in the mutant mice with homologous mutation of Timm8a1-I23fs49X
por: Ouattara, Niemtiah, et al.
Publicado: (2022)

Novel germline variants identified in the inner mitochondrial membrane transporter TIMM44 and their role in predisposition to oncocytic thyroid carcinomas
por: Bonora, E, et al.
Publicado: (2006)

Follicular helper-T cells restore CD8(+)-dependent antitumor immunity and anti-PD-L1/PD-1 efficacy
por: Niogret, Julie, et al.
Publicado: (2021)

Noncanonical PD-1/PD-L1 Axis in Relation to the Efficacy of Anti-PD Therapy
por: Long, Yiru, et al.
Publicado: (2022)

Safety and efficacy of anti-PD-1 in patients with baseline cardiac, renal, or hepatic dysfunction
por: Kanz, Bridgette A., et al.
Publicado: (2016)

The re-description of Synoecnemahirsutum Timm, 1959 (Synoecneminae, Ungellidae, Drilonematoidea) from a pheretimoid earthworm in Vietnam with the analysis of its phylogenetic relationships
por: Ivanova, Elena S., et al.
Publicado: (2021)

SLAMF8 expression predicts the efficacy of anti‐PD1 immunotherapy in gastrointestinal cancers
por: Zhang, Qun, et al.
Publicado: (2021)

Association of BRCA1- and BRCA2-deficiency with mutation burden, expression of PD-L1/PD-1, immune infiltrates, and T cell-inflamed signature in breast cancer
por: Wen, Wei Xiong, et al.
Publicado: (2019)

Abrogation of HnRNP L enhances anti-PD-1 therapy efficacy via diminishing PD-L1 and promoting CD8(+) T cell-mediated ferroptosis in castration-resistant prostate cancer
por: Zhou, Xumin, et al.
Publicado: (2022)

A Network Meta-analysis Comparing the Efficacy and Safety of Anti-PD-1 with Anti-PD-L1 in Non-small Cell Lung Cancer
por: You, Wei, et al.
Publicado: (2018)

The BRCA1 Methylation and PD-L1 Expression in Sporadic Ovarian Cancer
por: Zhu, Xinxin, et al.
Publicado: (2018)

The efficacy and safety of anti-PD-1/PD-L1 in treatment of glioma: a single-arm meta-analysis
por: Zeng, Yi-Fan, et al.
Publicado: (2023)

Prospects of the potential strategies to improve the efficacy of anti‐PD‐1/PD‐L1 therapy
por: Yamaguchi, Hirohito, et al.
Publicado: (2022)

Immunomodulatory effects of regorafenib: Enhancing the efficacy of anti-PD-1/PD-L1 therapy
por: Liu, Junjie, et al.
Publicado: (2022)

The global landscape of neoadjuvant and adjuvant anti-PD-1/PD-L1 clinical trials
por: Wu, Dawei, et al.
Publicado: (2022)

The efficacy of anti-PD-1/PD-L1 therapy and its comparison with EGFR-TKIs for advanced non-small-cell lung cancer
por: Sheng, Zhixin, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_0u9oabjslpdsmjbic23fkuso7k